EML4 and lung adenocarcinoma: Moreover, the co-existence of EGFR gene mutations, ALK gene fusions, and ROS1 gene rearrangements has been reported in a few lung adenocarcinoma cases [25–27], but the co-alteration of ROS1, EGFR, and EML4-ALK in MPA remains unclear.